Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02535936 · ClinicalTrials.gov registry record · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
A NA study of Spastic Diplegia, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT02535936: Recruiting NA study of Spastic Diplegia, sponsored by The University of Texas Health Science Center, Houston.
NCT02535936 is a NA study of Spastic Diplegia that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02535936, a NA study of Spastic Diplegia, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to characterize the cortical connectivity changes in the brain of spastic diplegic children after Selective Dorsal Rhizotomy.
Primary Outcome
This measure will be used to assess changes in the lower extremity fibers corticopyramidal tract after Selective Dorsal Rhizotomy (SDR).
Conditions Studied
Interventions
- PROCEDURE 3Tesla MRI with DTI-MRI and rsfcMRI under general anesthesia
Study Locations (1)
Texas
- UTHealth & Children's Memorial Hermann Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2015-08 |
| Est. Completion | 2031-01-01 |
| Phase | NA |
What NCT02535936 shows while recruiting
NCT02535936 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Spastic Diplegia appearing as the primary indexed condition, and to 1 intervention - of which 3Tesla MRI with DTI-MRI and rsfcMRI under general anesthesia is the first listed.
NCT02535936 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02535936 about?
NCT02535936 is a clinical study titled "Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy". The purpose of this study is to characterize the cortical connectivity changes in the brain of spastic diplegic children after Selective Dorsal Rhizotomy.
What is the current status of trial NCT02535936?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2015-08. Estimated completion is 2031-01-01.
What conditions does trial NCT02535936 study?
This clinical trial studies the following conditions: Spastic Diplegia.
What interventions are being tested in trial NCT02535936?
The interventions under investigation include: 3Tesla MRI with DTI-MRI and rsfcMRI under general anesthesia (PROCEDURE).
Who is sponsoring clinical trial NCT02535936?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02535936 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spastic Diplegia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02535936's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
- NCT02977468 · 15 participants · Phase 1
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia